Palanas, Jane D.
HRN: 23-90-85 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/21/2023
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
10/21/2023
10/27/2023
IV
285mg
OD
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamUnspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes